Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Digital Medicine Society (DiMe) is a global nonprofit professional society focused on advancing the safe, effective, equitable, and evidence-based use of digital medicine. Rather than a drug developer, DiMe convenes stakeholders across healthcare, life sciences, technology, policy, and research to create frameworks, educational programs, collaborative projects, and practical resources that support adoption of digital health technologies. Its work spans digital endpoints, clinical trials, AI in healthcare, patient-generated health data, connected sensors, and digital product evaluation. The organization also operates initiatives such as DATAcc, the Digital Medicine Academy, and DiMe Seal to improve measurement standards, trust, and implementation in digital health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Digital Medical Society.